
Company Number
04136579
Next Accounts
110 days late
Directors
Shareholders
vcare health limited
Group Structure
View All
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Registered Address
the cross farm house the cross, eastry, sandwich, CT13 0HG
Website
www.eastrypharmacyltd.co.ukPomanda estimates the enterprise value of EASTRY PHARMACY LIMITED at £564.1k based on a Turnover of £968.2k and 0.58x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of EASTRY PHARMACY LIMITED at £0 based on an EBITDA of £-173.5k and a 3.99x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of EASTRY PHARMACY LIMITED at £0 based on Net Assets of £-112.3k and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Eastry Pharmacy Limited is a live company located in sandwich, CT13 0HG with a Companies House number of 04136579. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in January 2001, it's largest shareholder is vcare health limited with a 100% stake. Eastry Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £968.2k with declining growth in recent years.
Pomanda's financial health check has awarded Eastry Pharmacy Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
4 Regular
7 Weak
Size
annual sales of £968.2k, make it smaller than the average company (£1.8m)
- Eastry Pharmacy Limited
£1.8m - Industry AVG
Growth
3 year (CAGR) sales growth of -10%, show it is growing at a slower rate (5.6%)
- Eastry Pharmacy Limited
5.6% - Industry AVG
Production
with a gross margin of 44.9%, this company has a comparable cost of product (44.9%)
- Eastry Pharmacy Limited
44.9% - Industry AVG
Profitability
an operating margin of -18.3% make it less profitable than the average company (5.9%)
- Eastry Pharmacy Limited
5.9% - Industry AVG
Employees
with 13 employees, this is below the industry average (17)
13 - Eastry Pharmacy Limited
17 - Industry AVG
Pay Structure
on an average salary of £48.8k, the company has an equivalent pay structure (£48.8k)
- Eastry Pharmacy Limited
£48.8k - Industry AVG
Efficiency
resulting in sales per employee of £74.5k, this is less efficient (£115.2k)
- Eastry Pharmacy Limited
£115.2k - Industry AVG
Debtor Days
it gets paid by customers after 47 days, this is near the average (57 days)
- Eastry Pharmacy Limited
57 days - Industry AVG
Creditor Days
its suppliers are paid after 81 days, this is slower than average (33 days)
- Eastry Pharmacy Limited
33 days - Industry AVG
Stock Days
it holds stock equivalent to 32 days, this is in line with average (32 days)
- Eastry Pharmacy Limited
32 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 12 weeks, this is less cash available to meet short term requirements (28 weeks)
12 weeks - Eastry Pharmacy Limited
28 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 123.6%, this is a higher level of debt than the average (52.7%)
123.6% - Eastry Pharmacy Limited
52.7% - Industry AVG
Eastry Pharmacy Limited's latest turnover from April 2023 is estimated at £968.2 thousand and the company has net assets of -£112.3 thousand. According to their latest financial statements, Eastry Pharmacy Limited has 13 employees and maintains cash reserves of £64.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Apr 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 13 | 13 | 13 | 12 | 21 | 15 | 14 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Apr 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 92,846 | 96,424 | 100,002 | 101,776 | 105,096 | 108,416 | 111,858 | 115,468 | 119,302 | 123,432 | 65,768 | 66,757 | 68,076 | 69,834 |
Intangible Assets | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 |
Investments & Other | ||||||||||||||
Debtors (Due After 1 year) | ||||||||||||||
Total Fixed Assets | 212,846 | 216,424 | 220,002 | 221,776 | 225,096 | 228,416 | 231,858 | 235,468 | 239,302 | 243,432 | 185,768 | 186,757 | 188,076 | 189,834 |
Stock & work in progress | 47,603 | 65,000 | 65,000 | 65,000 | 56,000 | 47,767 | 64,931 | 60,977 | 55,000 | 55,000 | 54,555 | 58,847 | 53,956 | 58,306 |
Trade Debtors | 126,693 | 239,177 | 247,468 | 220,332 | 206,673 | 231,093 | 202,818 | 214,398 | 264,419 | 263,762 | 351,379 | 398,746 | 406,607 | 438,419 |
Group Debtors | ||||||||||||||
Misc Debtors | 25,375 | 47,466 | 41,166 | 40,838 | 39,505 | 37,582 | 39,402 | 39,575 | ||||||
Cash | 64,106 | 239,118 | 146,460 | 73,915 | 139,181 | 176,966 | 94,423 | 119,761 | 117,311 | 147,191 | 31,059 | 9,200 | 38,205 | 11,225 |
misc current assets | ||||||||||||||
total current assets | 263,777 | 590,761 | 500,094 | 400,085 | 441,359 | 493,408 | 401,574 | 434,711 | 436,730 | 465,953 | 436,993 | 466,793 | 498,768 | 507,950 |
total assets | 476,623 | 807,185 | 720,096 | 621,861 | 666,455 | 721,824 | 633,432 | 670,179 | 676,032 | 709,385 | 622,761 | 653,550 | 686,844 | 697,784 |
Bank overdraft | 87,385 | 29,974 | 100,630 | 116,775 | 110,481 | 95,953 | 77,188 | 47,644 | ||||||
Bank loan | ||||||||||||||
Trade Creditors | 118,971 | 237,596 | 228,218 | 199,421 | 174,092 | 214,723 | 265,526 | 269,276 | 300,769 | 286,742 | 255,804 | 288,755 | 241,375 | 217,720 |
Group/Directors Accounts | ||||||||||||||
other short term finances | ||||||||||||||
hp & lease commitments | ||||||||||||||
other current liabilities | 56,573 | 21,963 | 49,524 | 17,793 | 13,252 | 12,549 | 20,192 | 24,893 | ||||||
total current liabilities | 262,929 | 289,533 | 378,372 | 333,989 | 297,825 | 323,225 | 362,906 | 341,813 | 300,769 | 286,742 | 255,804 | 288,755 | 241,375 | 217,720 |
loans | 325,969 | 415,333 | 242,758 | 279,828 | 353,627 | 355,418 | 182,782 | |||||||
hp & lease commitments | ||||||||||||||
Accruals and Deferred Income | ||||||||||||||
other liabilities | 221,358 | 193,150 | 215,559 | 110,126 | 62,550 | 79,749 | 69,284 | |||||||
provisions | ||||||||||||||
total long term liabilities | 325,969 | 415,333 | 242,758 | 279,828 | 353,627 | 355,418 | 182,782 | 221,358 | 193,150 | 215,559 | 110,126 | 62,550 | 79,749 | 69,284 |
total liabilities | 588,898 | 704,866 | 621,130 | 613,817 | 651,452 | 678,643 | 545,688 | 563,171 | 493,919 | 502,301 | 365,930 | 351,305 | 321,124 | 287,004 |
net assets | -112,275 | 102,319 | 98,966 | 8,044 | 15,003 | 43,181 | 87,744 | 107,008 | 182,113 | 207,084 | 256,831 | 302,245 | 365,720 | 410,780 |
total shareholders funds | -112,275 | 102,319 | 98,966 | 8,044 | 15,003 | 43,181 | 87,744 | 107,008 | 182,113 | 207,084 | 256,831 | 302,245 | 365,720 | 410,780 |
Apr 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 3,578 | 3,578 | 3,641 | 3,320 | 3,320 | 3,442 | 3,610 | 3,834 | 4,130 | 4,529 | 989 | 1,319 | 1,758 | 2,345 |
Amortisation | ||||||||||||||
Tax | ||||||||||||||
Stock | -17,397 | 9,000 | 8,233 | -17,164 | 3,954 | 5,977 | 445 | -4,292 | 4,891 | -4,350 | 58,306 | |||
Debtors | -134,575 | -1,991 | 27,464 | 14,992 | -22,497 | 26,455 | -11,753 | -10,446 | 657 | -87,617 | -47,367 | -7,861 | -31,812 | 438,419 |
Creditors | -118,625 | 9,378 | 28,797 | 25,329 | -40,631 | -50,803 | -3,750 | -31,493 | 14,027 | 30,938 | -32,951 | 47,380 | 23,655 | 217,720 |
Accruals and Deferred Income | 34,610 | -27,561 | 31,731 | 4,541 | 703 | -7,643 | -4,701 | 24,893 | ||||||
Deferred Taxes & Provisions | ||||||||||||||
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | ||||||||||||||
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | ||||||||||||||
Group/Directors Accounts | ||||||||||||||
Other Short Term Loans | ||||||||||||||
Long term loans | -89,364 | 172,575 | -37,070 | -73,799 | -1,791 | 172,636 | 182,782 | |||||||
Hire Purchase and Lease Commitments | ||||||||||||||
other long term liabilities | -221,358 | 28,208 | -22,409 | 105,433 | 47,576 | -17,199 | 10,465 | 69,284 | ||||||
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -175,012 | 92,658 | 72,545 | -65,266 | -37,785 | 82,543 | -25,338 | 2,450 | -29,880 | 116,132 | 21,859 | -29,005 | 26,980 | 11,225 |
overdraft | 57,411 | -70,656 | -16,145 | 6,294 | 14,528 | 18,765 | 29,544 | 47,644 | ||||||
change in cash | -232,423 | 163,314 | 88,690 | -71,560 | -52,313 | 63,778 | -54,882 | -45,194 | -29,880 | 116,132 | 21,859 | -29,005 | 26,980 | 11,225 |
Perform a competitor analysis for eastry pharmacy limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in CT13 area or any other competitors across 12 key performance metrics.
EASTRY PHARMACY LIMITED group structure
Eastry Pharmacy Limited has 1 subsidiary company.
Ultimate parent company
1 parent
EASTRY PHARMACY LIMITED
04136579
1 subsidiary
Eastry Pharmacy Limited currently has 1 director, Mr Chetan Bhatu serving since May 2023.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Chetan Bhatu | England | 40 years | May 2023 | - | Director |
P&L
April 2023turnover
968.2k
-32%
operating profit
-177k
0%
gross margin
44.9%
+1.35%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2023net assets
-112.3k
-2.1%
total assets
476.6k
-0.41%
cash
64.1k
-0.73%
net assets
Total assets minus all liabilities
company number
04136579
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
January 2001
age
24
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
April 2023
previous names
N/A
accountant
NEWMANS
auditor
-
address
the cross farm house the cross, eastry, sandwich, CT13 0HG
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to eastry pharmacy limited. Currently there are 3 open charges and 2 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EASTRY PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|